Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00962949 · ClinicalTrials.gov registry record · Phase 1
The Renin-Aldosterone Axis in Postural Tachycardia Syndrome
A Phase 1 study of Postural Orthostatic Tachycardia Syndrome (POTS), sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT00962949 is a Phase 1 study of Postural Orthostatic Tachycardia Syndrome (POTS) that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 28 participants, below the 103-participant average among 4 other Postural Orthostatic Tachycardia Syndrome (POTS) trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00962949, a Phase 1 study of Postural Orthostatic Tachycardia Syndrome (POTS), has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the role of the renin-angiotensin-aldosterone in the pathophysiology of postural tachycardia syndrome, and to provide an insight about the disease process in this disorder.
Conditions Studied
Interventions
- DRUG Angiotensin II
Study Locations (1)
Tennessee
- Vanderbilt University - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2009-04 |
| Est. Completion | 2012-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00962949
The ClinicalTrials.gov registry entry for NCT00962949 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 103-participant average among 4 other Postural Orthostatic Tachycardia Syndrome (POTS) trials with a reported enrollment target (73% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postural Orthostatic Tachycardia Syndrome (POTS) appearing as the primary indexed condition, and to 1 intervention - of which Angiotensin II is the first listed.
NCT00962949 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT00962949 about?
NCT00962949 is a clinical study titled "The Renin-Aldosterone Axis in Postural Tachycardia Syndrome". The purpose of this study is to determine the role of the renin-angiotensin-aldosterone in the pathophysiology of postural tachycardia syndrome, and to provide an insight about the disease process in this disorder.
What is the current status of trial NCT00962949?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2009-04. Estimated completion is 2012-12.
What conditions does trial NCT00962949 study?
This clinical trial studies the following conditions: Postural Orthostatic Tachycardia Syndrome (POTS).
What interventions are being tested in trial NCT00962949?
The interventions under investigation include: Angiotensin II (DRUG).
Who is sponsoring clinical trial NCT00962949?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00962949 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postural Orthostatic Tachycardia Syndrome (POTS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)
RECRUITING · Phase 2
-
Programming Aquatic Therapy for POTS
RECRUITING · NA
-
Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project
ACTIVE NOT RECRUITING
-
Abdominal and Lower Extremity Compression During Tilt Table Testing in Adolescent POTS Patients
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.